Emergent BioSolutions expands Adam Havey to EVP and COO effective July 26

Emergent BioSolutions Inc.

Adam Havey appointed Executive Vice President and Chief Operating Officer on July 20, 2021, effective July 26.
Havey, 50, joined Emergent in 2003 and previously served as EVP Business Operations since April 2017.
Reorganization of executive team approved by Board; Havey becomes principal operating officer.
He will oversee expanded responsibilities as part of the CEO's proposed restructuring.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Adam Havey

Executive Vice President and Chief Operating Officer

EBS · Emergent BioSolutions Inc.

Effective: 2021-07-26
Filed: July 22, 2021, 7:59 PM ET

In connection with that reorganization, Adam Havey’s role is expanded to Executive Vice President and Chief Operating Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Adam Havey changed role as Executive Vice President and Chief Operating Officer at Emergent BioSolutions Inc..

Action: expanded
Role: Executive Vice President and Chief Operating Officer

Exact text from the filing

In connection with that reorganization, Adam Havey’s role is expanded to Executive Vice President and Chief Operating Officer of the Company.

View on SEC.gov

Emergent BioSolutions Inc. filing history →

Source: SEC EDGAR

accession 0001367644-21-000110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.